Modified and immediate release memantine bead formulation

Details Modified and immediate release memantine bead formulation Modified and immediate release memantine bead formulation

A - Human Necessities

61

K

A61K 9/54 (2006.01) A61K 31/13 (2006.01)

Patent

CA 2607600

The present invention provides immediate release and modified release oral dosage forms. Specifically, the invention provides modified and immediate release pharmaceutical dosage forms containing memantine that exhibit an enhanced release profile and provide reliable absorption. The dosage forms may be used to treat mild, moderate or severe Alzheimer's disease or neuropathic pain.

L'invention porte sur des formes posologiques orales à libération immédiate et à libération modifiée. En particulier, l'invention concerne des formes posologiques à libération modifiée et immédiate contenant de la mémantine, qui présentent un profil de libération amélioré et une absorption fiable. Les formes posologiques de l'invention peuvent être utilisées pour traiter une maladie d'Alzheimer ou une douleur neuropathique légère, modérée ou sévère.

Affiliated with

Also associated with

Rating

Modified and immediate release memantine bead formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified and immediate release memantine bead formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified and immediate release memantine bead formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1873451